INHAL-101
/ Inhalis Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 21, 2023
Inhalis Therapeutics SA Achieves Key Milestone with Patent Application Filing
(PRNewswire)
- "Inhalis Therapeutics SA...proudly reveals a significant stride forward as it submits a new patent application on INHAL-101, its lead asset. This strategic move strengthens the company's positioning and enriches its intellectual property portfolio."
Patent • Idiopathic Pulmonary Fibrosis
1 to 1
Of
1
Go to page
1